HBsAg-negative, anti-hbc-negative patients still have a risk of hepatitis b virus-related hepatitis after autologous stem cell transplantation for multiple myeloma or malignant lymphoma

Hyunsung Park, Do Young Kim, Soo Jeong Kim, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, June Won Cheong, Yoo Hong Min, Jae Woo Song, Jin Seok Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)


Purpose Although hepatitis B surface antigen (HBsAg)-negative, hepatitis B core antibody (anti-HBc)- negative patients are not considered to be at risk for hepatitis B virus (HBV)-related hepatitis, the actual risk remains to be elucidated. This study aimed to evaluate the risk of HBV-related hepatitis in HBsAg-negative, anti-HBc-negative patients receiving autologous stem cell transplantation (ASCT) for multiple myeloma (MM) or malignant lymphoma. Materials and Methods We retrospectively reviewed data from 271 HBsAg-negative patients (161 anti-HBc-negative and 110 anti-HBc-positive at the time of ASCT) who received ASCT for MM or lymphoma. The risk of HBV-related hepatitis was analyzed according to the presence of anti-HBc. HBV serology results at the time of ASCT were compared with those at the time of diagnosis of MM or lymphoma. Results Three patients (two anti-HBc-negative MMs and one anti-HBc-positive MM) developed HBV-related hepatitis after ASCT. The rate of HBV-related hepatitis did not differ among patients with or without anti-HBc status (p=0.843). HBV-related hepatitis more frequently occurred in MM patients than in lymphoma patients (p=0.041). Overall, 9.1% of patients (16.7% with MM and 5.4% with lymphoma) who were HBsAg-negative and anti-HBc-positive at the time of diagnosis had lost anti-HBc positivity during chemotherapy prior to ASCT. Conclusion Our data suggest that HBsAg-negative, anti-HBc-negative patients at the time of ASCT for MM or lymphoma still might be at a risk for HBV-related hepatitis.

Original languageEnglish
Pages (from-to)1121-1129
Number of pages9
JournalCancer Research and Treatment
Issue number4
Publication statusPublished - 2018 Oct 1


All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this